{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:52:40Z","timestamp":1747158760922,"version":"3.40.5"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.cyto.2016.01.019","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:55:40Z","timestamp":1454633740000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Reverse kinetics of angiopoietin-2 and endotoxins in acute pyelonephritis: Implications for anti-inflammatory treatment?"],"prefix":"10.1016","volume":"81","author":[{"given":"Konstantinos","family":"Safioleas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-3911","authenticated-orcid":false,"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionyssia-Pinelopi","family":"Carrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aikaterini","family":"Pistiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambros","family":"Sabracos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalambos","family":"Deliveliotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Chrisofos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.01.019_b0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1186\/s12879-014-0639-4","article-title":"Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study","volume":"14","author":"Buonaiuto","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cyto.2016.01.019_b0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2016.01.019_b0015","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1286-4579(02)01613-1","article-title":"Toll receptors, CD14, and macrophage activation and deactivation by LPS","volume":"4","author":"Dobrovolskaia","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cyto.2016.01.019_b0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imlet.2009.06.006","article-title":"Angiopoietin-2 is increased in septic shock: evidence for the existence of a circulating factor stimulating its release from human monocytes","volume":"125","author":"Kranidioti","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2016.01.019_b0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/jpet.112.195180","article-title":"Angiopoietin-2 enhances survival in experimental sepsis induced by multidrug-resistant Pseudomonas aeruginosa","volume":"343","author":"Tzepi","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cyto.2016.01.019_b0030","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.pmed.0030046","article-title":"Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans","volume":"3","author":"Parikh","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.cyto.2016.01.019_b0035","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2016.01.019_b0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.juro.2014.03.092","article-title":"Immunomodulatory intervention with interferon-\u03b3 in Escherichia coli pyelonephritis","volume":"192","author":"Katsaris","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.cyto.2016.01.019_b0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/AAC.48.1.93-99.2004","article-title":"Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa","volume":"48","author":"Giamarellos-Bourboulis","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cyto.2016.01.019_b0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/422254","article-title":"Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study","volume":"190","author":"Marshall","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2016.01.019_b0055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.injury.2013.03.031","article-title":"Modulation of the release of Ang-2 in experimental endotoxic shock by a species-specific circulating factor","volume":"44","author":"Carrer","year":"2013","journal-title":"Injury"},{"key":"10.1016\/j.cyto.2016.01.019_b0060","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1164\/rccm.201204-0645OC","article-title":"Reversal of immunoparalysis in humans in vivo. A double-blind, placebo-controlled, randomized pilot study","volume":"186","author":"Leentjens","year":"2012","journal-title":"Am. J. Resp. Crit. Care Med."},{"key":"10.1016\/j.cyto.2016.01.019_b0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.CCM.0000251640.77679.D7","article-title":"Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators","volume":"35","author":"Orfanos","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2016.01.019_b0070","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.201208-1460OC","article-title":"Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients","volume":"187","author":"Agarwal","year":"2013","journal-title":"Am. J. Resp. Crit. Care Med."},{"key":"10.1016\/j.cyto.2016.01.019_b0075","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/CCM.0b013e3182451c87","article-title":"Plasma angiopoietin-2 in clinical acute lung injury prognostic and pathogenetic significance","volume":"40","author":"Calfe","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2016.01.019_b0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cyto.2015.01.022","article-title":"Angiopoietin-2 associations with the underlying infection and sepsis severity","volume":"73","author":"Lymperopoulou","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.01.019_b0085","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1097\/CCM.0000000000000524","article-title":"Lung-targeted RNA interference against angiopoietin-2 ameliorates multiple organ dysfunction and death in sepsis","volume":"42","author":"Stiehl","year":"2014","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2016.01.019_b0090","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2016.01.019_b0095","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00134-009-1726-7","article-title":"Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome","volume":"36","author":"K\u00fcmpers","year":"2010","journal-title":"Intens. Care Med."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616300187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T14:28:01Z","timestamp":1537021681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616300187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":19,"alternative-id":["S1043466616300187"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.01.019","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reverse kinetics of angiopoietin-2 and endotoxins in acute pyelonephritis: Implications for anti-inflammatory treatment?","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}